Indacaterol er en én gang dagligt inhaleret β 2-agonist til behandling af kronisk obstruktiv lungesygdom

Translated title of the contribution: [Indacaterol is a new once-daily beta2-agonist for treatment of COPD]
1 Citation (Scopus)

Fingerprint

Dive into the research topics of '[Indacaterol is a new once-daily beta2-agonist for treatment of COPD]'. Together they form a unique fingerprint.

Medicine & Life Sciences